- Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study
-
Kim JM, Kim SS, Kim JH, Kim MK, Kim TN, Lee SH, Lee CW, Park JY, Kim ES, Lee KJ, Choi YS, Kim DK, Kim IJ
- KMID: 2470956
- Diabetes Metab J.
- 2020 Feb;44(1):67-77.
- doi: 10.4093/dmj.2018.0274
BACKGROUND: There is limited information regarding the optimal third-line therapy for managing type 2 diabetes mellitus (T2DM) that is inadequately controlled using dual combination therapy. This study assessed the efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01
-
Kim YZ, Kim CY, Wee CW, Roh TH, Hong JB, Oh HJ, Kang SG, Kang SH, Kong DS, Kim SH, Kim SH, Kim SH, Kim YJ, Kim EH, Kim IA, Kim HS, Park JS, Park HJ, Song SW, Sung KS, Yang SH, Yoon WS, Yoon HI, Lee J, Lee ST, Lee SW, Lee YS, Lim J, Chang JH, Jung TY, Jung HL, Cho JH, Choi SH, Choi HS, Lim DH, Chung DS, KSNO Guideline Working Group
- KMID: 2461179
- Brain Tumor Res Treat.
- 2019 Oct;7(2):74-84.
- doi: 10.14791/btrt.2019.7.e43
BACKGROUND: There was no practical guideline for the management of patients with central nervous system tumor in Korea for many years. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary... -
- CITED
-
- Close
- SHARE
-
- Close
- The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01
-
Kim YZ, Kim CY, Lim J, Sung KS, Lee J, Oh HJ, Kang SG, Kang SH, Kong DS, Kim SH, Kim SH, Kim SH, Kim YJ, Kim EH, Kim IA, Kim HS, Roh TH, Park JS, Park HJ, Song SW, Yang SH, Yoon WS, Yoon HI, Lee ST, Lee SW, Lee YS, Wee CW, Chang JH, Jung TY, Jung HL, Cho JH, Choi SH, Choi HS, Hong JB, Lim DH, Chung DS, KSNO Guideline Working Group
- KMID: 2461178
- Brain Tumor Res Treat.
- 2019 Oct;7(2):63-73.
- doi: 10.14791/btrt.2019.7.e42
BACKGROUND: There was no practical guideline for the management of patients with central nervous system tumor in Korea in the past. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
-
Kim MJ, Kim SM, Jung HA, Hong JY, Chang WJ, Choi MK, Kim HS, Sun JM, Park K, Ahn MJ
- KMID: 2457034
- Korean J Intern Med.
- 2019 Sep;34(5):1107-1115.
- doi: 10.3904/kjim.2017.234
BACKGROUND/AIMS: We investigated the efficacy and toxicity of a weekly schedule of docetaxel and cisplatin as a first-line treatment in patients with recurrent or metastatic head and neck squamous cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
-
Yang HK, Lee SH, Shin J, Choi YH, Ahn YB, Lee BW, Rhee EJ, Min KW, Yoon KH
- KMID: 2454058
- Diabetes Metab J.
- 2019 Jun;43(3):287-301.
- doi: 10.4093/dmj.2018.0054
BACKGROUND: We evaluated the efficacy and safety of acarbose add-on therapy in Korean patients with type 2 diabetes mellitus (T2DM) who are inadequately controlled with metformin and sitagliptin. METHODS: A total... -
- CITED
-
- Close
- SHARE
-
- Close
- Is Second Look Laparoscopy for Diagnosing Remaining Ovarian Cancer Appropriate Further Treatment?
-
Inamdar R, Cho A, Yoo HK, Moon HS
- KMID: 2444726
- Ewha Med J.
- 2019 Apr;42(2):15-19.
- doi: 10.12771/emj.2019.42.2.15
OBJECTIVES: The aim of our study is to compare the findings of investigative modalities and second look laparoscopy in ovarian cancer and establish the safety and accuracy of second look... -
- CITED
-
- Close
- SHARE
-
- Close
- Associated Factors for Target Blood Pressure Achievement after Triple Combination Therapy in Hypertensive Patients
-
Jeon YR, Jung SH, Kang SY, Kim YS, Jeon TH, Lee S, Yang YJ, Kim SM, Yoon JL
- KMID: 2442654
- Korean J Health Promot.
- 2019 Mar;19(1):16-24.
- doi: 10.15384/kjhp.2019.19.1.16
BACKGROUND: The prevalence of hypertension reaches 29% in adults over 30 years of age in the Korean population; however, the control rate is merely 44%. The aim of this study... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer
-
Kim JW, Kim JG, Kang BW, Chung IJ, Hong YS, Kim TY, Song HS, Lee KH, Zang DY, Ko YH, Song EK, Baek JH, Koo D, Oh SY, Cho H, Lee KW
- KMID: 2437615
- Cancer Res Treat.
- 2019 Jan;51(1):223-239.
- doi: 10.4143/crt.2018.073
PURPOSE: The purpose of this study was to evaluate chemotherapy patterns and changes in quality of life (QOL) during first-line palliative chemotherapy for Korean patients with unresectable or metastatic/recurrent gastric... -
- CITED
-
- Close
- SHARE
-
- Close
- Fludarabine and Rituximab in Relapsed or Refractory Hairy Cell Leukmia Variant: A Case Report and Review of Literature
-
Lee JW, Choi YM, Yang JY, Han SM, Kim BS, Nam SH
- KMID: 2442557
- Kosin Med J.
- 2018 Dec;33(3):438-445.
- doi: 10.7180/kmj.2018.33.3.438
Hairy cell leukemia (HCL) is a rare chronic B cell leukemia morphologically characterized by cells with an abundant cytoplasm and hair-like projections that can be found in the peripheral blood... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Nab-Paclitaxel Plus Gemcitabine and Prognostic Value of Peripheral Neuropathy in Patients with Metastatic Pancreatic Cancer
-
You MS, Ryu JK, Choi YH, Choi JH, Huh G, Paik WH, Lee SH, Kim YT
- KMID: 2427464
- Gut Liver.
- 2018 Nov;12(6):728-735.
- doi: 10.5009/gnl18220
BACKGROUND/AIMS: The combination of nab-paclitaxel and gemcitabine (nab-P/Gem) is widely used for treating meta-static pancreatic cancer (MPC). We aimed to evaluate the therapeutic outcomes and prognostic role of treatment-related peripheral... -
- CITED
-
- Close
- SHARE
-
- Close
- Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
-
Yoo C, Han B, Kim HS, Kim KP, Kim D, Jeong JH, Lee JL, Kim TW, Kim JH, Choi DR, Ha HI, Seo J, Chang HM, Ryoo BY, Zang DY
- KMID: 2424804
- Cancer Res Treat.
- 2018 Oct;50(4):1324-1330.
- doi: 10.4143/crt.2017.526
PURPOSE: Although gemcitabine plus cisplatin has been established as the standard first-line chemotherapy for patients with advanced biliary tract cancer (BTC), overall prognosis remains poor. We investigated the efficacy of... -
- CITED
-
- Close
- SHARE
-
- Close
- Patterns of rpoC Mutations in Drug-Resistant Mycobacterium tuberculosis Isolated from Patients in South Korea
-
Yun YJ, Lee JS, Yoo JC, Cho E, Park D, Kook YH, Lee KH
- KMID: 2414564
- Tuberc Respir Dis.
- 2018 Jul;81(3):222-227.
- doi: 10.4046/trd.2017.0042
BACKGROUND: Rifampicin (RFP) is one of the principal first-line drugs used in combination chemotherapies against Mycobacterium tuberculosis, and its use has greatly shortened the duration of chemotherapy for the successful... -
- CITED
-
- Close
- SHARE
-
- Close
- Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer
-
Shin W, Lee HJ, Yang SJ, Paik ES, Choi HJ, Kim TJ, Choi CH, Lee JW, Bae DS, Kim BG
- KMID: 2416123
- Obstet Gynecol Sci.
- 2018 May;61(3):352-358.
- doi: 10.5468/ogs.2018.61.3.352
OBJECTIVE: This retrospective study is to evaluate the efficacy and toxicity of combination chemotherapy with etoposide and ifosfamide (ETI) in the management of pretreated recurrent or persistent epithelial ovarian cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease
-
Jang H, Kim KY, Kim DS
- KMID: 2418857
- Yonsei Med J.
- 2018 Jan;59(1):113-118.
- doi: 10.3349/ymj.2018.59.1.113
PURPOSE: Intravenous immunoglobulin (IVIG) is the standard treatment for Kawasaki disease (KD). However, there is still no standard treatment for IVIG-resistant KD. This study aimed to evaluate the efficacy of... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study
-
Ayhan A, Ozkan NT, Sarı ME, Celik H, Dede M, Akbayır O, Güngördük K, Şahin H, Haberal A, Güngör T, Arvas M, Meydanlı
- KMID: 2395239
- J Gynecol Oncol.
- 2018 Jan;29(1):e12.
- doi: 10.3802/jgo.2018.29.e12
OBJECTIVE: The purpose of this study was to investigate the prognostic value of lymph node ratio (LNR) in patients with stage III ovarian high-grade serous carcinoma (HGSC). METHODS: A multicenter, retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term recurrence-free survival of a patient with advanced pure primary ovarian squamous cell carcinoma treated with dose-dense paclitaxel combined with carboplatin
-
Yazawa H, Hiraiwa T, Ito F, Fujimori K
- KMID: 2418361
- Obstet Gynecol Sci.
- 2017 Nov;60(6):587-592.
- doi: 10.5468/ogs.2017.60.6.587
We describe an extremely rare case of advanced pure primary ovarian squamous cell carcinoma (SCC), treated by adjuvant chemotherapy with dose-dense paclitaxel combined with carboplatin (dd-TC) plus the combination chemotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
-
Heo EJ, Cho YJ, Cho WC, Hong JE, Jeon HK, Oh DY, Choi YL, Song SY, Choi JJ, Bae DS, Lee YY, Choi CH, Kim TJ, Park WY, Kim BG, Lee JW
- KMID: 2394811
- Cancer Res Treat.
- 2017 Oct;49(4):915-926.
- doi: 10.4143/crt.2016.322
PURPOSE: Patient-derived tumor xenografts (PDXs) can provide more reliable information about tumor biology than cell line models. We developed PDXs for epithelial ovarian cancer (EOC) that have histopathologic and genetic... -
- CITED
-
- Close
- SHARE
-
- Close
- API5 induces cisplatin resistance through FGFR signaling in human cancer cells
-
Jang HS, Woo SR, Song KH, Cho H, Chay DB, Hong SO, Lee HJ, Oh SJ, Chung JY, Kim JH, Kim TW
- KMID: 2394305
- Exp Mol Med.
- 2017 Sep;49(9):e374.
- doi: 10.1038/emm.2017.130
Most tumors frequently undergo initial treatment with a chemotherapeutic agent but ultimately develop resistance, which limits the success of chemotherapies. As cisplatin exerts a high therapeutic effect in a variety... -
- CITED
-
- Close
- SHARE
-
- Close
- Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial
-
Seo J, Kim WS, Kim JS, Kim SJ, Lee JH, Hong JS, Lee GW, Oh SY, Lee JH, Yoon DH, Lee WS, Kim HJ, Kwak JY, Kang HJ, Jo JC, Park Y, Lee HS, Kim HJ, Suh C
- KMID: 2390982
- Blood Res.
- 2017 Sep;52(3):200-206.
- doi: 10.5045/br.2017.52.3.200
BACKGROUND: Rituximab plus cyclophosphamide, vincristine, and prednisone (R-CVP) is one of the effective chemotherapeutic regimens for patients with advanced stage marginal zone lymphoma (MZL). However, prognostic factors that affect the... -
- CITED
-
- Close
- SHARE
-
- Close
- Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus
-
Tamai H, Ida Y, Kawashima , Shingaki N, Shimizu R, Moribata K, Nasu T, Maekita T, Iguchi M, Kato J, Nakao T, Kitano M
- KMID: 2412236
- Gut Liver.
- 2017 Jul;11(4):551-558.
- doi: 10.5009/gnl16525
BACKGROUND/AIMS: The present study aimed to evaluate the safety and efficacy of simeprevir-based triple therapy with reduced doses of pegylated interferon (PEG-IFN) and ribavirin for interferon (IFN) ineligible patients, such... -
- CITED
-
- Close
- SHARE
-
- Close
